The mechanism of the inhibitory action of neurotensin on pentagastrin-stimulated gastric secretion in dogs

L. Mate, H. R. Doyle, T. Sakamoto, Courtney Townsend, G. H. Greeley, J. C. Thompson

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Neurotensin is a potent inhibitor of pentagastrin-stimulated gastric acid secretion. This study was done to investigate the possible role of vagal innervation and of prostaglandins on this inhibitory effect. Five dogs with gastric cannulas were infused with pentagastrin (1 microgram per kilogram of body weight each hour) for 210 minutes. In the 60 to 150 minute period, neurotensin (5.5 micrograms per kilogram of body weight each hour) was infused. Neurotensin significantly decreased pentagastrin-stimulated gastric acid output, while the simultaneous administration of indomethacin (bolus of 1 milligram per kilogram of body weight plus infusion of 0.5 milligrams per kilogram each hour) abolished the effect of neurotensin. After truncal vagotomy, the inhibitory effect of neurotensin was again studied. Since the sensitivity of the stomach to pentagastrin decreased after vagotomy, the dose of pentagastrin was doubled (2 micrograms per kilogram of body weight each hour) in order to achieve acid stimulation comparable with the levels before vagotomy. After vagotomy, neurotensin inhibited the effect of pentagastrin in a manner similar to that shown before vagotomy. The inhibitory potency of neurotensin on gastrin-stimulated gastric secretion is independent of the vagus, but requires intact synthesis for prostaglandins.

Original languageEnglish (US)
Pages (from-to)206-210
Number of pages5
JournalSurgery Gynecology and Obstetrics
Volume166
Issue number3
StatePublished - 1988

Fingerprint

Pentagastrin
Neurotensin
Stomach
Dogs
Vagotomy
Body Weight
Gastric Acid
Prostaglandins
Truncal Vagotomy
Gastrins
Indomethacin
Acids

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Surgery

Cite this

The mechanism of the inhibitory action of neurotensin on pentagastrin-stimulated gastric secretion in dogs. / Mate, L.; Doyle, H. R.; Sakamoto, T.; Townsend, Courtney; Greeley, G. H.; Thompson, J. C.

In: Surgery Gynecology and Obstetrics, Vol. 166, No. 3, 1988, p. 206-210.

Research output: Contribution to journalArticle

Mate, L. ; Doyle, H. R. ; Sakamoto, T. ; Townsend, Courtney ; Greeley, G. H. ; Thompson, J. C. / The mechanism of the inhibitory action of neurotensin on pentagastrin-stimulated gastric secretion in dogs. In: Surgery Gynecology and Obstetrics. 1988 ; Vol. 166, No. 3. pp. 206-210.
@article{8a1754ed35ba481c8988eb9bda17bf3d,
title = "The mechanism of the inhibitory action of neurotensin on pentagastrin-stimulated gastric secretion in dogs",
abstract = "Neurotensin is a potent inhibitor of pentagastrin-stimulated gastric acid secretion. This study was done to investigate the possible role of vagal innervation and of prostaglandins on this inhibitory effect. Five dogs with gastric cannulas were infused with pentagastrin (1 microgram per kilogram of body weight each hour) for 210 minutes. In the 60 to 150 minute period, neurotensin (5.5 micrograms per kilogram of body weight each hour) was infused. Neurotensin significantly decreased pentagastrin-stimulated gastric acid output, while the simultaneous administration of indomethacin (bolus of 1 milligram per kilogram of body weight plus infusion of 0.5 milligrams per kilogram each hour) abolished the effect of neurotensin. After truncal vagotomy, the inhibitory effect of neurotensin was again studied. Since the sensitivity of the stomach to pentagastrin decreased after vagotomy, the dose of pentagastrin was doubled (2 micrograms per kilogram of body weight each hour) in order to achieve acid stimulation comparable with the levels before vagotomy. After vagotomy, neurotensin inhibited the effect of pentagastrin in a manner similar to that shown before vagotomy. The inhibitory potency of neurotensin on gastrin-stimulated gastric secretion is independent of the vagus, but requires intact synthesis for prostaglandins.",
author = "L. Mate and Doyle, {H. R.} and T. Sakamoto and Courtney Townsend and Greeley, {G. H.} and Thompson, {J. C.}",
year = "1988",
language = "English (US)",
volume = "166",
pages = "206--210",
journal = "Journal of the American College of Surgeons",
issn = "1072-7515",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - The mechanism of the inhibitory action of neurotensin on pentagastrin-stimulated gastric secretion in dogs

AU - Mate, L.

AU - Doyle, H. R.

AU - Sakamoto, T.

AU - Townsend, Courtney

AU - Greeley, G. H.

AU - Thompson, J. C.

PY - 1988

Y1 - 1988

N2 - Neurotensin is a potent inhibitor of pentagastrin-stimulated gastric acid secretion. This study was done to investigate the possible role of vagal innervation and of prostaglandins on this inhibitory effect. Five dogs with gastric cannulas were infused with pentagastrin (1 microgram per kilogram of body weight each hour) for 210 minutes. In the 60 to 150 minute period, neurotensin (5.5 micrograms per kilogram of body weight each hour) was infused. Neurotensin significantly decreased pentagastrin-stimulated gastric acid output, while the simultaneous administration of indomethacin (bolus of 1 milligram per kilogram of body weight plus infusion of 0.5 milligrams per kilogram each hour) abolished the effect of neurotensin. After truncal vagotomy, the inhibitory effect of neurotensin was again studied. Since the sensitivity of the stomach to pentagastrin decreased after vagotomy, the dose of pentagastrin was doubled (2 micrograms per kilogram of body weight each hour) in order to achieve acid stimulation comparable with the levels before vagotomy. After vagotomy, neurotensin inhibited the effect of pentagastrin in a manner similar to that shown before vagotomy. The inhibitory potency of neurotensin on gastrin-stimulated gastric secretion is independent of the vagus, but requires intact synthesis for prostaglandins.

AB - Neurotensin is a potent inhibitor of pentagastrin-stimulated gastric acid secretion. This study was done to investigate the possible role of vagal innervation and of prostaglandins on this inhibitory effect. Five dogs with gastric cannulas were infused with pentagastrin (1 microgram per kilogram of body weight each hour) for 210 minutes. In the 60 to 150 minute period, neurotensin (5.5 micrograms per kilogram of body weight each hour) was infused. Neurotensin significantly decreased pentagastrin-stimulated gastric acid output, while the simultaneous administration of indomethacin (bolus of 1 milligram per kilogram of body weight plus infusion of 0.5 milligrams per kilogram each hour) abolished the effect of neurotensin. After truncal vagotomy, the inhibitory effect of neurotensin was again studied. Since the sensitivity of the stomach to pentagastrin decreased after vagotomy, the dose of pentagastrin was doubled (2 micrograms per kilogram of body weight each hour) in order to achieve acid stimulation comparable with the levels before vagotomy. After vagotomy, neurotensin inhibited the effect of pentagastrin in a manner similar to that shown before vagotomy. The inhibitory potency of neurotensin on gastrin-stimulated gastric secretion is independent of the vagus, but requires intact synthesis for prostaglandins.

UR - http://www.scopus.com/inward/record.url?scp=0023925589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023925589&partnerID=8YFLogxK

M3 - Article

C2 - 3344449

AN - SCOPUS:0023925589

VL - 166

SP - 206

EP - 210

JO - Journal of the American College of Surgeons

JF - Journal of the American College of Surgeons

SN - 1072-7515

IS - 3

ER -